References
[1] Ahmad, M., Usman, M., Madni, A., 2011. A fast and simple HPLC-UV method for simultaneous determination of three anti-cancer agents in plasma of breast cancer patients and its application to clinical pharmacokinetics.
Afr J Pharm Pharmacol, 5(7):915-922.
[2] Arambewela, L., Arawwawala, M., Rajapaksa, D., 2006.
Piper betle: a potential natural antioxidant.
Int J Food Sci Technol, 41(s1):10-14.
[3] Boyer, J., McLean, E.G., Aroori, S., 2004. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.
Clin Cancer Res, 10(6):2158-2167.
[4] Bunz, F., Hwang, P.M., Torrance, C., 1999. Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
J Clin Invest, 104(3):263-269.
[5] Cabrera, J., Mancuso, M., Cabrera-Franquiz, F., 2011. Stability and compatibility of the mixture of tramadol, ketorolac, metoclopramide and ranitidine in a solution for intravenous perfusion.
Farm Hosp, (in Spanish),35(2):80-83.
[6] Chakraborty, J.B., Mahato, S.K., Joshi, K., 2012. Hydroxychavicol, a
Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species-dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance.
Cancer Sci, 103(1):88-99.
[7] Chang, M., Uang, B., Wu, H.L., 2002. Inducing the cell cycle arrest and apoptosis of oral KB carcinoma cells by hydroxychavicol: roles of glutathione and reactive oxygen species.
Brit J Pharmacol, 135(3):619-630.
[8] Chou, T.C., 2006. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies.
Pharmacol Rev, 58(3):621-681.
[9] Esimone, C.O., 2011. Drug-drug and herb-drug interaction—a comment.
J Res Nat Dev, 9(1):47-59.
[10] Fathilah, A.R., Sujata, R., Norhanom, A.W., 2010. Antiproliferative activity of aqueous extract of
Piper betle L. and
Psidium guajava L. on KB and HeLa cell lines.
J Med Plants Res, 4(11):987-990.
[11] Felth, J., Rickardson, L., Rosen, J., 2009. Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs.
J Nat Prod, 72(11):1969-1974.
[12] Fishbein, A.B., Wang, C.Z., Li, X.L., 2009. Asian ginseng enhances the anti-proliferative effect of 5-fluorouracil on human colorectal cancer: comparison between white and red ginseng.
Arch Pharm Res, 32(4):505-513.
[13] Guha, P., 2006. Betel leaf: the neglected green gold of India.
J Hum Ecol, 19(2):87-93.
[14] Hemamalini, V., Dass Prakash, M.V., Sivaramakrishnan, S., 2012. Evaluation of the
in vitro antioxidant, anti-enteropathogenic and anticancer efficacy of natural and synthetic hydroxychavicol.
Int J Medicobiol Res, 1(5):250-254.
[15] Hiss, D.C., Gabriels, G.A., Folb, P.I., 2007. Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells.
Cancer Cell Int, 7(1):5
[16] Hrmann, V., Kumi-Diaka, J., Durity, M., 2012. Anticancer activities of genistein-topotecan combination in prostate cancer cells.
J Cell Mol Med, 16(11):2631-2636.
[17] Hussin, A.H., 2001. Adverse effects of herbs and drug-herbal interactions.
Malays J Pharm, 1(2):39-44.
[18] Jeng, J., Chen, S., Liao, C., 2002. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase.
Free Radic Biol Med, 32(9):860-871.
[19] Jeng, J.H., Wang, Y.J., Chang, W.H., 2004. Reactive oxygen species are crucial for hydroxychavicol toxicity toward KB epithelial cells.
Cell Mol Life Sci, 61(1):83-96.
[20] Jin, J., Huang, M., Wei, H.L., 2002. Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel
7402
.
World J Gastroenterol, 8(6):1029-1034.
[21] Kinsella, A., Smith, D., Pickard, M., 1997. Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage.
Brit J Cancer, 75(7):935-945.
[22] Klampfer, L., Swaby, L.A., Huang, J., 2005. Oncogenic Ras increases sensitivity of colon cancer cells to 5-FU-induced apoptosis.
Oncogene, 24(24):3932-3941.
[23] Kumar, N., Misra, P., Dube, A., 2010.
Piper betle Linn. a maligned Pan-asiatic plant with an array of pharmacological activities and prospects for drug discovery.
Curr Sci, 99(7):922-932.
[24] Kumar, S., Choudhary, S., Singh, N., 2012. Combination of natural drugs: an emerging trend in cancer chemotherapy.
J Drug Deliv Ther, 2(3):97-105.
[25] Mader, R.M., Mller, M., Steger, G.G., 1998. Resistance to 5-fluorouracil.
Gen Pharmacol, 31(5):661-666.
[26] Majumdar, A.P., Banerjee, S., Nautiyal, J., 2009. Curcumin synergizes with resveratrol to inhibit colon cancer.
Nutr Cancer, 61(4):544-553.
[27] Molyneux, P., 2004. The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity.
Songklanakarin J Sci Technol, 26(2):211-219.
[28] Nakagawa, Y., Suzuki, T., Nakajima, K., 2009. Biotransformation and cytotoxic effects of hydroxychavicol, an intermediate of safrole metabolism, in isolated rat hepatocytes.
Chem Biol Interact, 180(1):89-97.
[29] Newton, D.W., 2009. Drug incompatibility chemistry.
Am J Health Syst Pharm, 66(4):348-357.
[30] Noordhuis, P., Holwerda, U., van der Wilt, C., 2004. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers.
Ann Oncol, 15(7):1025-1032.
[31] Pin, K., Chuah, A.L., Rashid, A.A., 2010. Antioxidant and anti-inflammatory activities of extracts of betel leaves (
Piper betle) from solvents with different polarities.
J Trop For Sci, 22(4):448-455.
[32] Pin, K.Y., Ilicali, C., Luqman Chuah, A., 2011. Modelling of freezing kinetics of extract of betel leaves (
Piper betle L.).
Int J Food Eng, 7(1):Art. 15
[33] Pizzorno, G., Diasio, R.B., Cheng, Y.C., 2009. Cancer Medicine. Peoples Medical Publishing House-USE,USA :
[34] Pourcel, L., Routaboul, J.M., Cheynier, V., 2007. Flavonoid oxidation in plants: from biochemical properties to physiological function.
Trends Plant Sci, 12(1):29-36.
[35] Renuka, G., Thiruvengadarajan, V.S., Amruthkumar, N., 2011. A review on herb-drug interactions.
Int J Pharm Res Dev, 3(3):136-153.
[36] Slovin, S., 2012. Chemotherapy and immunotherapy combination in advanced prostate cancer.
Clin Adv Hematol Oncol, 10(2):90-100.
[37] Tallarida, R.J., Raffa, R.B., 1996. Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram.
Life Sci, 58(2):23-28.
[38] Tang, X.Y., Zhu, Y.Q., Tao, W.H., 2007. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.
Postgrad Med J, 83(979):338-343.
[39] Tong, J., Xie, G., He, J., 2011. Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer.
J Biomed Biotechnol, 2011:740564
[40] Wang, C.Z., Yuan, C.S., 2008. Potential role of ginseng in the treatment of colorectal cancer.
Am J Chin Med, 36(6):1019-1028.
[41] Yamai, H., Sawada, N., Yoshida, T., 2009. Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells
in vitro and suppress experimental metastasis
in vivo
.
Int J Cancer, 125(4):952-960.
[42] Young, S.C., Wang, C.J., Hsu, J.D., 2006. Increased sensitivity of HepG2 cells toward the cytotoxicity of cisplatin by the treatment of
Piper betel leaf extract.
Arch Toxicol, 80(6):319-327.
[43] Zong, W.X., Thompson, C.B., 2006. Necrotic death as a cell fate.
Genes Dev, 20(1):1-15.
Open peer comments: Debate/Discuss/Question/Opinion
<1>